Loading viewer...
conference
Format: PDF conference
Regeneron Pharmaceuticals presented its strategy and business update at the J.P. Morgan Healthcare Conference in January 2023, featuring insights from CEO Leonard S. Schleifer. The presentation covered the company's pipeline including EYLEA, Dupixent, Libtayo, and other product candidates, along with forward-looking clinical and commercial developments.
investor_presentation
23 Pages
conference
39 Pages
Zions Bancorporation
Calumet Specialty Products 2022 Barclays Leveraged Finance Conference
conferenceconference
32 Pages
Calumet Specialty Products Partners
Karyopharm Therapeutics 2024 HC Wainwright Conference Presentation
conferenceconference
34 Pages
Karyopharm Therapeutics Inc.
Lifezone Metals 2023 Precious Metals Summit Presentation
conferenceconference
16 Pages
Lifezone Metals Limited
Synchrony Financial 2016 Conference Presentation
conferenceconference
15 Pages
Synchrony Financial